Computational and Structural Biotechnology Journal 24 ( 2024 ) 53 â€“ 65 Available online 7 December 2023 2001 - 0370 / Â© 2023 The Author ( s ) . Published by Elsevier B . V . on behalf of Research Network of Computational and Structural Biotechnology . This is an open access article under the CC BY license ( http : / / creativecommons . org / licenses / by / 4 . 0 / ) . Contents lists available at ScienceDirect Computational and Structural Biotechnology Journal journal homepage : www . elsevier . com / locate / csbj Research Article Corticosteroid treatment prediction using chest X - ray and clinical data Anzhelika Mezina a , âˆ— , Samuel Genzor b , âˆ— , Radim Burget a , Vojtech Myska a , Jan Mizera b , Aleksandr Ometov c a Brno University of Technology , FEEC , Dept . of Telecommunications , Technicka 12 , Brno , 616 00 , Czech Republic b Center for Digital Health , Palacky Univesity Olomouc , Faculty of Medicine and Dentistry , Hnevotinska 976 / 3 , Olomouc 779 00 , Czech Republic c Electrical Engineering Unit , Faculty of Information Technology and Communication Sciences , Tampere University , Tampere , 33720 , Finland A R T I C L E I N F O A B S T R A C T Keywords : Image classiï¬cation Chest X - ray images Vision transformer Treatment prediction Clinical data Post - acute COVID - 19 Background and Objective : Severe courses of COVID - 19 disease can lead to long - term complications . The post - acute phase of COVID - 19 refers to the persistent or new symptoms . This problem is becoming more relevant with the increasing number of patients who have contracted COVID - 19 and the emergence of new virus variants . In this case , preventive treatment with corticosteroids can be applied . However , not everyone beneï¬ts from the treatment , moreover , it can have severe side eï¬€ects . Currently , no study would analyze who beneï¬ts from the treatment . Methods : This work introduces a novel approach to the recommendation of Corticosteroid ( CS ) treatment for patients in the post - acute phase . We have used a novel combination of clinical data , including blood tests , spirometry , and X - ray images from 273 patients . These are very challenging to collect , especially from patients in the post - acute phase of COVID - 19 . To our knowledge , no similar dataset exists in the literature . Moreover , we have proposed a unique methodology that combines machine learning and deep learning models based on Vision Transformer ( ViT ) and InceptionNet , preprocessing techniques , and pretraining strategies to deal with the speciï¬c characteristics of our data . Results : The experiments have proved that combining clinical data with CXR images achieves 8 % higher accuracy than independent analysis of CXR images . The proposed method reached 80 . 0 % accuracy ( 78 . 7 % balanced accuracy ) and a ROC - AUC of 0 . 89 . Conclusions : The introduced system for CS treatment prediction using our neural network and learning algorithm is unique in this ï¬eld of research . Here , we have shown the eï¬ƒciency of using mixed data and proved it on real - world data . The paper also introduces the factors that could be used to predict long - term complications . Additionally , this system was deployed to the hospital environment as a recommendation tool , which admits the clinical application of the proposed methodology . 1 . Introduction Since 2020 , the pandemic SARS - COV - 2 ( COVID - 19 ) aï¬€ected the lives of all people in the world . Although some cases have been re - ported as asymptomatic COVID - 19 infections [ 1 ] , almost 7 million cases ( November 2023 ) of COVID - 19 were fatal according to World Health Organization ( WHO ) statistics . Despite rapid and continuous improvements in prevention , diagnos - tics , and treatment , dealing with possible consequences and complica - tions in severe disease courses is still necessary . Those complications ( including thromboses , decompensation of comorbid diseases , and ï¬ - * Corresponding authors . E - mail addresses : anzhelika . mezina @ vut . cz ( A . Mezina ) , samuel . genzor @ fnol . cz ( S . Genzor ) , burgetrm @ vut . cz ( R . Burget ) , vojtech . myska @ vut . cz ( V . Myska ) , jan . mizera @ fnol . cz ( J . Mizera ) , aleksandr . ometov @ tuni . ï¬ ( A . Ometov ) . nally , pulmonary ï¬brosis ( PF ) ) may lead to increased morbidity and mortality [ 2 ] . One of the common complications of severe COVID - 19 courses may be the subsequent development of PF [ 3 ] . Such compli - cations can be detected during the post - acute phase of COVID - 19 ( so - called long COVID ) . Preventive treatment with corticosteroids ( CS ) is one of the ways to decrease the risk . Nonetheless , not all patients beneï¬t from CS treatment , and , more - over , this medication is connected to numerous severe side eï¬€ects [ 4 â€“ 7 ] . Some studies found that non - selected applications of CS treatment may be harmful [ 8 , 9 ] , and it is still unclear which patients may receive this therapy . https : / / doi . org / 10 . 1016 / j . csbj . 2023 . 11 . 057 Received 26 September 2023 ; Received in revised form 27 November 2023 ; Accepted 28 November 2023 Computational and Structural Biotechnology Journal 24 ( 2024 ) 53 â€“ 65 54 A . Mezina , S . Genzor , R . Burget et al . Fig . 1 . The overall scheme of experiments for proposed recommendation system of CS treatment . Currently , there is still a lack of studies that would make per - sonalized recommendations on which patients will beneï¬t from the CS treatment and who will not . Additionally , not so many works use the combined clinical data for analysis because of the diï¬ƒculty of collecting them . According to WHO statistics , there are 100 , 000 infec - tions on average a week ( at least in November 2023 ) , and there is a higher risk of development of PF after the severe acute phase of COVID - 19 [ 10 ] . The objective of this paper is to ï¬nd the relation between a pa - tientâ€™s clinical condition in the post - acute phase of COVID - 19 at the beginning of treatment and the probability of beneï¬t from CS treatment using clinical information and chest X - ray image of the patient . Sometimes , patients may not be recommended to receive this medication and can avoid possible side eï¬€ects . To achieve this goal , we retrospectively analyzed the data from 273 patients showing the results of ( non - ) application of CS treatment and applied several techniques to preprocess this clinical data . We fur - ther proposed an ML - based and DL - based methodology that predicts whether the CS treatment is recommended or not based on the patientâ€™s clinical data and the CXR . The application of artiï¬cial intelligence ( AI ) is an appropriate way because of its capability to process a large num - ber of parameters and to ï¬nd the relations in these data . The described experiment has two parts : 1 . CXR images have been used to predict whether the CS treatment is necessary . This part is performed using our novel deep learning ( DL ) architecture ; 2 . CXR images and data retrieved from spirometry , blood information , and anamnesis of the patientâ€™s state of health were processed using our DL architecture and ML with a preprocessing of features . During these experiments , we show that such a combination of in - formation , such as clinical data and CXR images , provides about 8 % better accuracy than when it is used separately . The overall scheme of the experiment is depicted in Fig . 1 . The main contributions of this paper are : â€¢ Developed DL - based approach for treatment prediction for one of the most frequent long - term COVID - 19 complications . The method - ology is unique , and there is no comparable one published for this disease yet . â€¢ The proposed approach combines traditional machine learning methods for clinical data processing and our architecture of the neu - ral network , which consists of Vision Transformer and InceptionNet , for analysis of CXR images . â€¢ This study shows that combining clinical data and CXR images can give more accurate results than when used separately . â€¢ A wide range of parameters from patientsâ€™ anamnesis was analyzed , and the most statistically signiï¬cant parameters were identiï¬ed . â€¢ The proposed framework was integrated into the internal hospital system as a part of the recommendation tool . â€¢ The dataset with clinical data and CXR from patients is introduced and available in [ 11 ] . The rest of the paper is structured as follows . Section 2 represents related work and describes relevant solutions based on utilizing mixed data and predicting treatment of other health problems . Next , Section 3 provides more details about the introduced methodology and neural network and the following prediction of CS necessity using clinical and CXR data . Further , Section 4 shows and discusses the experiment re - sults . The last Section 5 concludes the paper . 2 . Related work This Section represents the latest works and approaches that focus on applying AI in the related research ï¬elds to the stated problem . Firstly , the relevant DL methods for CXR processing are introduced . Sec - ondly , the overview of methods for processing mixed data is presented . Lastly , the application of ML for treatment prediction is provided . 2 . 1 . Chest X - ray image analysis CXR and Computed Tomography ( CT ) are mandatory and the most important diagnostic methods in pulmonology [ 12 ] . Since the amount of radiation received from a CXR is approximately 70 Ã— lower than the Computational and Structural Biotechnology Journal 24 ( 2024 ) 53 â€“ 65 55 A . Mezina , S . Genzor , R . Burget et al . radiation received from CT [ 13 ] , the CXR is still preferred for a general patientâ€™s examination due to possible consequent risks . Therefore , the widespread task in the research ï¬eld is the analysis of CXR images , often performed using DL methods . These methods can be useful as an assistant tool for the radiologist [ 14 ] . One of the frequently used ways to construct the neural network for that is to use pre - trained models , such as ResNet [ 15 ] , DenseNet [ 16 ] , InceptionNet [ 17 ] , etc . , and to add some new blocks or modules , which help to adapt the model for a given problem . For example , the VGG16 with attention module distinguishes between COVID - 19 , viral , bacterial pneumonia , and normal [ 18 ] . Or , the same classes were detected us - ing Eï¬ƒcientNet - B5 with noisy student in [ 19 ] . Also , the approach [ 20 ] utilizes the pre - trained VGG16 model and several augmentation tech - niques ( conventional method , mixup , and Random Image Cropping and Patching ( RICAP ) ) to prevent the overï¬tting of the model . One of the ï¬rst approaches related to COVID - 19 detection is de - scribed in [ 21 ] . The authors proposed an ensemble deep learning model consisting of Densenet - 121 , Resnet - 50 , InceptionNet , Inception - Resnet , XCeption , and Eï¬ƒcientNet - B2 . As the input to the model , four images were generated : cropped and uncropped with sizes of 224 Ã— 224 px and 331 Ã— 331 px . The work results demonstrate that the achieved accuracy of 83 % is comparable with the consensus of experienced thoracic radi - ologists . The strategy of several branches is also applied in another work [ 22 ] . The authors used 20 individually trained deep neural networks to de - tect COVID - 19 and non - COVID - 19 pneumonia . This ensemble model achieved an AUC of 0 . 92 . The mentioned models can also be modi - ï¬ed , as was done in [ 23 ] . The MobileNet network was adapted here for CXR image classiï¬cation to avoid the gradient vanishing problem and overï¬tting . Another work [ 24 ] performed experiments for COVID - 19 detection using pre - trained models Eï¬ƒcientNetB1 , NasNetMobile , and MobileNetV2 and achieved an accuracy of 96 % . Eï¬ƒcientNet was also applied for COVID - 19 detection in [ 25 ] . The proposed method has incorporated uncertainty into Eï¬ƒcientNetB3 . Some works describe the models , combining some pre - trained well - known models , as done in [ 26 ] . The authors proposed a model consist - ing of MobileNetV2 and VGG16 , and the ï¬nal classiï¬cation is performed with the concatenation of these two branches . The authors classiï¬ed CXR images into COVID - 19 , Normal , Pneumonia Viral , and Pneumo - nia Bacterial . InceptionNetV3 can also be applied for this task [ 27 ] . Additionally to that , CycleGAN was used for data augmentation . Also , a possible way is to use the convolutional network , which consists of convolutional and max pooling layers . According to the authors of work [ 28 ] , it is possible to achieve an accuracy of 99 % for COVID - 19 detection . According to the studied literature , many approaches focus on pro - cessing CXR obtained from the acute phase of COVID - 19 and detecting viral and bacterial pneumonia and COVID - 19 . However , there is no at - tention to the post - acute phase of this disease . 2 . 2 . Analysis of mixed medical data In medical research , data analysis can be done over images , clini - cal data , or a combination of both . Such a combination of data can give much more information , and consequently , it can increase the accu - racy of AI methods [ 29 ] . Such application is also actual in a pandemic , where predicting the possible complications is necessary . It can assist in prescribing treatment or clinical outcomes and help organize hospi - tal resources . With this motivation , the authors of work [ 30 ] proposed a method - ology that uses mixed data to identify patients at risk of severe conse - quences , which can lead to intensive care or death . The article described three data - processing approaches : handcrafted , hybrid , and end - to - end learning . The best - achieved accuracy is 76 . 9 % , which is produced by a hybrid method . Another work [ 31 ] uses mixed data in an end - to - end manner . The proposed neural network consists of two branches : CNN , which pro - cesses CXR images , and MLP , which consists of two dense layers for numerical data processing . The goal is to diï¬€erentiate between COVID - 19 and non - COVID - 19 patients . According to the results , the model has achieved 95 . 4 % accuracy . The comparison of three diï¬€erent scenarios , diagnosis of COVID - 19 using clinical data with a fully connected neural network , CXR images with Eï¬ƒcientNetB7 , and a combination of both , is introduced in [ 32 ] . The authors used data from 270 patients . The most accurate case is the combination of clinical data and CXR images , which achieved an accuracy of 97 % . The disease severity and progression are also described in [ 33 ] . For the experiment , the Eï¬ƒcientNet for image - based severity prediction and a neural network with some dense layers for clinical - data - based severity prediction are used to perform the ï¬nal severity prediction . Combined progression prediction is performed using a so - called survival forest for output of the dense layer with 256 neurons from the previously men - tioned models for images , clinical parameters , and chest CXR severity scores . The results show that the image and clinical data combination performs better for severity prediction ( ROC - AUC 0 . 792 ) and progres - sion prediction ( C - index 0 . 752 ) on the external test set . Another application of DL to mixed data is represented in [ 34 ] . The methodology consists of the following steps : 1 ) the 3D CNN ex - tracts the features from CT images , the clinical data are concatenated , 2 ) dimensionality reduction is performed with the Principal Compo - nent Analysis ( PCA ) method , 3 ) ï¬nal classiï¬cation is performed using CatBoost . The algorithm is aimed to predict categories of patients : who needed intensive care unit admission or were dead and who were healed and moved to non - COVID wards for further care . The achieved results are promising : AUC of 0 . 949 . Currently , most studies using mixed data focus exclusively on the acute phase of COVID - 19 treatment . However , no approach analyzes data from the post - acute phase of COVID - 19 . In this way , our work ï¬lls the gap in research by providing analysis using AI of patientsâ€™ CXR and clinical data from the post - acute phase . 2 . 3 . Treatment recommendation Another research question is whether it is possible to predict the response to some treatment or an optimal dose of medication using AI . One of our latest research works [ 35 ] is primarily focused on CS treatment prediction , but it is based only on clinical data of patients . This approach compared several ML algorithms , such as Logistic Re - gression , k - NN , Decision Tree , XGBoost , Random Forest , SVM , MLP , AdaBoost , and LGBM , for the mentioned problem . The best - achieved results belong to the decision tree with a balanced accuracy of 73 . 52 % . Some works have already been focused on this task , but for other ï¬elds of medicine . One of the popular ï¬elds of research is related to cancer . For example , the work [ 36 ] proposes the two - staged DL frame - work , which consists of tumor segmentation and response prediction . The results show that the segmentation component is essential to re - sponse prediction . Another approach combines the information from the CT image and clinical data [ 37 ] . The article retrospectively analyzes the outcome predictions for individualized radiotherapy doses . The proposed model predicts treatment failures with a C - index of 0 . 72 . Also , ML was applied to predict insuï¬ƒcient response to methotrex - ate in patients with Rheumatoid Arthritis [ 38 ] . The results show logistic regression is the most successful in this task , and achieved an AUC of 0 . 77 . On the other hand , some works focused on predicting the outcome of treatment for COVID - 19 [ 39 ] . For example , work [ 40 ] proposes a DL framework with Whale Optimization Algorithm ( WOA ) , which uti - lizes CT images and some additional information about patients ( age , infection stage , etc . ) and is aimed to predict the patientâ€™s response to treatment during the acute phase . Computational and Structural Biotechnology Journal 24 ( 2024 ) 53 â€“ 65 56 A . Mezina , S . Genzor , R . Burget et al . Table 1 Comparison of related works . Ref . Problem solved Method Results Medical analysis using CXR data ( classiï¬cation ) [ 23 ] COVID - 19 , bact . pneumonia , viral pneumonia , tuberculosis , normal Modiï¬ed MobileNet Accuracy 0 . 997 COVID - 19 , Non - COVID - 19 infection , normal Accuracy 0 . 996 COVID - 19 , Non - COVID - 19 pneumonia , tuberculosis , normal Accuracy 0 . 999 [ 24 ] COVID - 19 , viral pneumonia , normal , lung opacity Eï¬ƒcientNetB1 Accuracy 0 . 961 [ 25 ] COVID - 19 , normal , pneumonia Eï¬ƒcientNet - B3 + Monte Carlo Accuracy 0 . 980 COVID - 19 , normal Accuracy 0 . 994 [ 26 ] COVID - 19 , normal , pneumonia MobileNetV2 + VGG16 Accuracy 0 . 965 COVID - 19 , normal , bacterial pneumonia , viral pneumonia Accuracy 0 . 902 [ 27 ] COVID - 19 , non - COVID - 19 Inception - CycleGAN Accuracy 0 . 942 [ 28 ] COVID - 19 , normal , bacterial pneumonia , viral pneumonia 22 - layers CNN Accuracy 0 . 912 COVID - 19 , normal , bacterial pneumonia Accuracy 0 . 942 COVID - 19 , normal Accuracy 0 . 991 [ 21 ] COVID - 19 , non - COVID - 19 Deep learning ensemble model Accuracy 0 . 83 [ 22 ] COVID - 19 pneumonia , non - COVID - 19 pneumonia Deep learning ensemble model with 20 branches AUC 0 . 92 Medical data analysis using mixed data [ 30 ] COVID - 19 mild or severe GoogleNet + SVM Accuracy 0 . 769 [ 31 ] COVID - 19 and non - COVID - 19 CNN + MLP Accuracy 0 . 963 [ 32 ] COVID - 19 and non - COVID - 19 Eï¬ƒcientB7 + MLP Accuracy 0 . 97 [ 33 ] Disease severity ( critical / non - critical ) Eï¬ƒcientNetB0 + MLP AUC 0 . 792 Progression prediction ( time - to - event outcome ) Eï¬ƒcientNetB0 + survival forest C - Index 0 . 752 [ 34 ] Severity ( non - ICU and ICU ) CNN + CatBoost AUC 0 . 949 Prediction of treatment [ 35 ] Response to CS treatment in post - acute COVID - 19 Decision tree Balanced accuracy 0 . 735 [ 36 ] Pathologic complete response Convolutional Encoder - Decoder AUC 0 . 97 [ 37 ] Predicting treatment failures Encoder - decoder + regression model C - Index 0 . 72 [ 38 ] Prediction of insuï¬ƒcient response to methotrexate Logistic regression AUC 0 . 77 [ 40 ] Prediction of response to COVID - 19 treatment CNN for CT segmentation + SVM + WOA Accuracy 0 . 971 2 . 4 . Related work summary All approaches mentioned in this section are summed up in Table 1 . Considering the studied literature and the current state of technolo - gies , it can be concluded that there is no work focusing on retrospective analysis based on clinical data and CXR images of patientsâ€™ COVID - 19 post - acute phase . Additionally , no ML / DL approach would recommend treatment for one of the most severe long - term post - COVID complica - tions , except our work . This way , we aim to ï¬ll the gap in the research ï¬eld because our work represents the analysis of such data and provides a unique dataset with a combination of the clinical data and CXR im - ages and a detailed statistical evaluation of the proposed methodology . 3 . Methodology This section introduces a DL - based approach to recommend preven - tive CS treatment for one of the most severe long - term post - COVID - 19 complications â€“ PF . First , data are preprocessed , including image processing and selec - tion from the clinical data . Then , the recently proposed our neural network and the following comparison with other architectures are de - scribed . Finally the two scenarios of experiments : 1 ) with only CXR images , and 2 ) a combination of CXR and clinical data , are introduced . Generally , the experiment consists of the following steps ( see Fig . 1 ) : 1 . Training our neural network on open large dataset ChestX - ray14 [ 41 ] and comparing it with other well - known architectures to select the most successful architecture for further use ; 2 . Testing trained model selected from the previous step on given CXR images to determine the necessity of CS ( experiment 1 ) ; 3 . Statistical evaluation and selection of most signiï¬cant parameters from clinical data ; 4 . Application of DL and ML to combined data : CXR image and se - lected parameters from clinical data ( experiment 2 ) . The dataset [ 11 ] and source code [ 42 ] are available online . 3 . 1 . Data preparation One of the main parts of ML methods is data preparation . Generally , this phase consists of CXR image preprocessing , parameter selection , and labeling . 3 . 1 . 1 . Custom dataset In this work , the new dataset with CXR images and clinical data of patients from post - acute COVID - 19 is introduced and provided by Uni - versity Hospital Olomouc , Czech Republic . Patientsâ€™ data were collected during the initial check - up , which is 4 â€“ 12 weeks after the acute onset of COVID - 19 . All of the examinations , including blood tests , CXR , and pulmonary function tests , were performed at the same time . The dataset has a total of 273 patients , where the information about the necessity of CS is given : 141 patients will not beneï¬t from CS treat - ment , and 132 will beneï¬t from it . It is essential to note that all of the patients requiring CS treatment had pneumonia during the acute phase of COVID - 19 . In addition , all of those patients had persisting pulmonary involvement . However , in a signiï¬cant proportion of the patients , there was spontaneous regression of the lung damage . The model aimed to identify those with proï¬t from CS therapy . This dataset includes more than 100 parameters , including blood test values , pulmonary function test ( spirometry ) , the patientâ€™s anamnesis , clinical condition , and X - ray images as summarized in Table 2 . Notably , several patients had negative or N / A results for COVID - 19 testing â€“ anti - SARS - CoV - 2 IgG . COVID - 19 was diagnosed with very suspicious clinical symptoms , radiology images , and the presence of anti - SARS - CoV - 2 IgM antibodies ( only in non - vaccinated individuals at the beginning of the epidemic ) . 3 . 1 . 2 . Parameters selection The parameter selection from the clinical data represented with quantitative and categorical numbers is essential for avoiding over - ï¬tting . The clinical data consist of information taken at the time of initiation of post - COVID treatment . In this step , the parameters are pre - Computational and Structural Biotechnology Journal 24 ( 2024 ) 53 â€“ 65 57 A . Mezina , S . Genzor , R . Burget et al . Table 2 Description of patientsâ€™ clinical data from the custom dataset . Number of patients 273 Demographic and habits Attributes Values Gender Male Female 166 107 Age STD Mean Minimum - Maximum 11 . 18 64 . 38 30 - 90 Body parameters Weight ( kg ) 15 . 87 88 . 03 57 - 136 Height ( cm ) 9 . 84 170 . 01 145 - 198 BMI 4 . 98 30 . 47 20 . 75 - 47 . 37 Therapy and lung damage Attributes Number of patients Yes No Hospitalized 222 51 Oxygen ( O2 ) 179 94 Remdesevir 22 251 CS During hospitalization 99 174 Post - COVID - 19 treatment 92 181 Another diagnostics 4 269 HRCT â€“ lung damage Interstitial involvement 49 224 Inï¬‚ammatory changes 118 155 Persistent health issues Attributes Number of patients Yes No N / A Dyspnea 188 84 1 Cough 93 179 1 Fatigue 77 195 1 Olfactory loss 39 234 0 Gastrointestinal problems 68 205 0 COVID - 19 Testing Attributes Number of patients Positive Negative N / A IgM ( qualit . ) 219 47 7 IgG ( qualit . ) 264 2 7 Vaccination Attributes Number of patients Yes No N / A 1st dozen 11 210 52 2nd dozen 3 206 64 3rd dozen 1 90 182 selected based on two statistical methods and manual selection . The feature selection is depicted in Fig . 3 . The ï¬rst one is SHapley Additive exPlanations ( SHAP ) [ 43 ] , which explains the feature importance for a given ML method , i . e . , the Deci - sion Tree in our case . The output is depicted in Fig . 2 . As can be seen , the amount of CS received during the treatment ( i . e . , dose Ã— period ) ( CS _ amount ) and Immunoglobulin M antibodies ( IgM ) ( SARS - CoV - 2 IgM ( quant . ) ) values from blood tests signiï¬cantly impact CS treatment . IgM indicates an early immune response after infection in the body . Another statistical method used was ğ‘˜ - highest scores based on ğ‘ - values [ 44 ] . The common parameters of both methods are the amount of used CS ( CS _ amount ) , peripheral blood monocytes % ( KO _ Mo % ) , and Expiratory Reserve Volume ( ERV ) ( ERV ( abs ) ) values . From the ğ‘˜ - best method following features were selected : CS use ( CS ) , olfactory loss ( olfactory _ loss ) , post - COVID disability ( postcovid _ disability ) , level of speciï¬c anti - SARS - CoV - 2 immunoglobulin M antibodies ( SARS - CoV - 2 IgM ( quant . ) ) , the dose of CS ( CS _ amount ) , duration of CS ( CS _ dura - tion _ weeks ) , red cell distribution width ( RDW ) ( KO _ RDW ) , vital capac - ity ( VC ) ( absolute ) ( VC ( abs ) ) , forced expiratory volume in 1 second FEV1 ( absolute ) ( FEV1 ( abs ) ) , and peak expiratory ï¬‚ow ( PEF ) ( % of pre - dicted ) ( PEF ( % pred ) ) . Fig . 2 . Feature importance analysis based on SHAP method using the decision tree . Additionally , some other parameters were pre - selected manually af - ter series of trials to achieve the best eï¬€ect of CS prediction . These parameters correlate with the severity of the pneumonia and impact the persisting pulmonary damage , leading to an indication of CS treat - ment . A brief description of selected ones is introduced below : â€¢ Pneumonia â€“ patients with this variable have had COVID - 19 pneu - monia ; â€¢ CS another problems â€“ patients received CS treatment due to other indications ; â€¢ SARS - CoV - 2 IgG ( qualit . ) â€“ presence of IgG antibodies against COVID - 19 ; â€¢ FVC ( % pred ) â€“ forced vital capacity ( % of predicted values ) ; â€¢ DLCOcSB ( abs . ) â€“ lung diï¬€using capacity for carbon monoxide ( ab - solute values ) , which is a transfer factor ( i . e . correlate of alveolar volume ) ; â€¢ KCOcSB ( abs . ) â€“ lung diï¬€using capacity for carbon monoxide ( abso - lute values ) , which is a transfer coeï¬ƒcient ( i . e . correlate of alveolar diï¬€usion ) ; â€¢ Persistent cough â€“ presence of long - lasting cough after COVID - 19 ( for more than 4 weeks ) ; â€¢ Persistent dyspnea â€“ presence of long - lasting dyspnea after COVID - 19 ( for more than 4 weeks ) ; â€¢ MEF25 ( abs . ) â€“ maximal expiratory ï¬‚ow at 25 % of vital capacity . The ï¬nal set of features contains the following : Presence of pneu - monia at the acute COVID - 19 phase , comorbidity , CS use , olfactory loss during the acute COVID - 19 phase , post - COVID - 19 disability , SARS - CoV - 2 IgG ( qualit . ) , SARS - CoV - 2 IgM ( quant . ) , amount of used CS , total used CS , duration of CS use in weeks , RDW , VC ( abs ) , FVC ( % pred ) , FEV1 ( abs ) , Mo % , PEF ( % pred ) , DLCOc ( abs ) , KCOc ( abs ) , persistent cough , persistent dyspnea and MEF25 ( abs ) . Computational and Structural Biotechnology Journal 24 ( 2024 ) 53 â€“ 65 58 A . Mezina , S . Genzor , R . Burget et al . Fig . 3 . Selection of clinical parameters from custom dataset . 3 . 1 . 3 . Data labeling The clinical data also contains information about the objective radi - ological score , which reï¬‚ects the lung damage regression in the range of 0 ( immutable state ) to 10 ( complete regression ) . This parameter gives information on whether the patientâ€™s health has improved . Patients with scores between 0 and 6 are not considered to have signiï¬cantly im - proved their health status . For the values 7 - 10 , it is considered that their status improved . Considering this information , it was possible to determine the necessity of CS , i . e . , whether the patient will beneï¬t from the CS treatment . The dataset was split into training and testing subsets . The training set has 218 patients ( 111 â€“ not recommended , 107 â€“ rec - ommended ) . The testing set has 55 patients ( 30 â€“ not recommended , 25 â€“ recommended ) . 3 . 1 . 4 . Chest X - ray image preparation The CXR images were cropped to the area of interest for all experi - ments . This step uses a pre - trained U - Net [ 45 ] model for lung segmen - tation , used in [ 21 ] . This step helps the neural network to focus on the lungs instead of considering the surrounding area . Another important step is data augmentation to reduce the modelâ€™s possible overï¬tting . For this purpose , transformations ( e . g . , translation , rotation , and zoom ) were applied to extend the dataset during the train - ing . This work uses two datasets with CXR images : the ChestX - ray14 dataset [ 41 ] for pre - training and our custom dataset for CS prediction . ChestX - ray14 has a total of 112 , 120 images with 14 pulmonary diseases : Atelectasis , Cardiomegaly , Consolidation , Edema , Eï¬€usion , Emphysema , Fibrosis , Hernia , Inï¬ltration , Mass , Nodule , Pleural thick - ening , Pneumonia , and Pneumothorax . Among the mentioned diseases , some images do not have any disease . It is one of the most frequently used datasets in this ï¬eld of research . However , the images with at least one pulmonary disease were selected for this experiment . The dataset was divided into training ( 36 , 024 images ) and testing ( 15 , 735 images ) parts according to the oï¬ƒcial dataset split . Also , the validation set is 20 % of the training set . 3 . 2 . Neural network for feature extraction from X - ray images A neural network is selected for image processing in this part of the experiment . First , the description of our architecture of the neural network [ 46 ] is presented . Then , a comparison with other well - known architectures is performed . Fig . 4 . Scheme of the inception module . 3 . 2 . 1 . Architecture The recently proposed neural network is aimed to perform the clas - siï¬cation task over CXR images . The ï¬rst step is to classify images from the ChestX - ray14 dataset , which is prepared for multilabel classiï¬ca - tion . That is why the following description will be focused on multilabel classiï¬cation . The overall scheme is introduced in Fig . 5 . This architecture applies the strategy of two branches to capture global and local features . This concept has been widely used in litera - ture [ 26 , 47 , 48 ] . On the one hand , using only one branch is not so eï¬€ec - tive , according to the results presented in the following sections . On the other hand , applying more branches increases the modelâ€™s complexity , making it more computationally demanding . That is why the optimal solution in this case is using two branches . The ï¬rst branch aims to ex - tract the global features and is represented with InceptionNetV3 [ 17 ] . After InceptionNetV3 , GlobalMaxPooling , Dense , and Dropout layers are used for the ï¬nal classiï¬cation . The second branch consists of four parts . First , feature extraction is performed with three inception mod - ules . Fig . 4 shows the architecture of the inception module . After the inception modules , the Vision Transformer ( ViT ) [ 49 ] was utilized for the following processing . Fig . 6 shows the architecture of ViT in more detail . The concatenation of two branches consists of three dense layers with 64 , 32 , and 14 units to provide the ï¬nal results . The last layer Computational and Structural Biotechnology Journal 24 ( 2024 ) 53 â€“ 65 59 A . Mezina , S . Genzor , R . Burget et al . Fig . 5 . Scheme of the proposed neural network . Fig . 6 . Scheme of the transformer network used in the proposed architecture . has a sigmoid activation function since it is necessary to perform the multilabel classiï¬cation . Considering that the dataset is slightly imbalanced , the Asymmet - ric Loss ( ASL ) function was used [ 50 ] . Additionally , it was modiï¬ed : instead of binary cross - entropy , the focal loss function was applied . Mathematically , it has a uniï¬ed formula ( more details can be found in the original paper ) [ 50 ] : ğ´ğ‘†ğ¿ = { ğ¿ + = ( 1 âˆ’ ğ‘ ) ğ›¾ + log ( ğ‘ ) , ğ¿ âˆ’ = ( ğ‘ ğ‘š ) ğ›¾ âˆ’ log ( 1 âˆ’ ğ‘ ğ‘š ) , ( 1 ) where ğ¿ + and ğ¿ âˆ’ are the positive and negative loss parts , ğ‘ is the output probability from the network , ğ‘ ğ‘š is the shifted probability , ğ›¾ is the focusing parameter . The set up parameters are ğ›¾ âˆ’ is 5 , ğ›¾ + is 1 , clip is 0 . 001 . The focal loss function is described in [ 51 ] : ğ¹ğ¿ ( ğ‘ ğ‘¡ ) = âˆ’ ğ›¼ ğ‘¡ ( 1 âˆ’ ğ‘ ğ‘¡ ) ğ›½ log ( ğ‘ ğ‘¡ ) , ( 2 ) where ğ‘ ğ‘¡ is the modelâ€™s estimated probability for the class with label ğ‘¦ = 1 , ğ›¼ ğ‘¡ is the balancing factor , and ğ›½ is the modulating factor . 3 . 2 . 2 . Comparison with traditional methods To compare the proposed model with other methods , some well - known architectures for image classiï¬cation were selected : DenseNet121 [ 16 ] , Eï¬ƒcientNetB4 [ 52 ] , InceptionNetV3 [ 17 ] , ResNet101 [ 15 ] and VGG16 [ 53 ] . These models were also trained on the ChestX - ray14 dataset to detect diseases in CXR . The following values were used for hyper - parameter tuning for all the mentioned architectures , including our architecture : batch size â€“ 8 , number of steps per epoch â€“ 1000 , num - Computational and Structural Biotechnology Journal 24 ( 2024 ) 53 â€“ 65 60 A . Mezina , S . Genzor , R . Burget et al . Table 3 Evaluation of the achieved results by all methods . Method AUC Sensitivity Speciï¬city Accuracy Precision F1 Score DenseNet121 0 . 7667 0 . 7169 0 . 6965 0 . 7022 0 . 2324 0 . 3234 Eï¬ƒcientNetB4 0 . 7772 0 . 7079 0 . 7221 0 . 7223 0 . 2419 0 . 3324 ResNet101 0 . 7520 0 . 7011 0 . 6917 0 . 6975 0 . 2320 0 . 3232 VGG16 0 . 7797 0 . 7427 0 . 6930 0 . 6978 0 . 2433 0 . 3357 InceptionNetV3 0 . 7522 0 . 7073 0 . 6869 0 . 6864 0 . 2314 0 . 3171 Our model 0 . 7952 0 . 7281 0 . 7326 0 . 7334 0 . 2541 0 . 3478 Table 4 Detailed AUC results achieved with all methods for each disease . Pathology DenseNet121 Eï¬ƒcientNetB4 ResNet101 VGG16 InceptionNetV3 Our model Atelectasis 0 . 7325 0 . 7421 0 . 7450 0 . 7587 0 . 7379 0 . 7610 Cardiomegaly 0 . 8513 0 . 8594 0 . 8518 0 . 8684 0 . 8423 0 . 8789 Consolidation 0 . 6635 0 . 6663 0 . 6665 0 . 6890 0 . 6614 0 . 6983 Edema 0 . 8208 0 . 8187 0 . 8128 0 . 8253 0 . 7902 0 . 8313 Eï¬€usion 0 . 7886 0 . 7858 0 . 7944 0 . 8058 0 . 7815 0 . 8062 Emphysema 0 . 8313 0 . 8490 0 . 8088 0 . 8673 0 . 8147 0 . 8865 Fibrosis 0 . 7921 0 . 8263 0 . 7983 0 . 7888 0 . 7999 0 . 8330 Hernia 0 . 8549 0 . 8910 0 . 6222 0 . 7860 0 . 7138 0 . 8787 Inï¬ltration 0 . 6791 0 . 6850 0 . 6762 0 . 7035 0 . 6727 0 . 6978 Mass 0 . 7797 0 . 7803 0 . 7865 0 . 8073 0 . 7773 0 . 8123 Nodule 0 . 7306 0 . 7442 0 . 7427 0 . 7541 0 . 7216 0 . 7657 Pleural Thickening 0 . 7011 0 . 7222 0 . 7181 0 . 7258 0 . 7138 0 . 7376 Pneumonia 0 . 6632 0 . 6644 0 . 6594 0 . 6786 0 . 6684 0 . 6778 Pneumothorax 0 . 8446 0 . 8461 0 . 8455 0 . 8576 0 . 8346 0 . 8676 ber of epochs â€“ 100 , optimizer â€“ AdamW , learning rate â€“ 0 . 0001 , weight decay â€“ 0 . 00001 . All mentioned methods used as a baseline apply the binary cross - entropy as a loss function . Tables 3 and 4 represent the results of trained models . The perfect and maximum value for each metric is 1 . Based on the results , it can be concluded that the proposed model achieves better accuracy than other neural network architectures with AUC â€“ 0 . 7952 , speciï¬city â€“ 0 . 7326 , accuracy â€“ 0 . 7334 , precision â€“ 0 . 2541 , and F1 score â€“ 0 . 3478 . The Eï¬ƒcientNetB4 model has worse results than the proposed model but has achieved better results among other methods from the baseline . It has an AUC of 0 . 7772 , sensitivity of 0 . 7079 , speciï¬city of 0 . 7221 , accuracy of 0 . 7223 , precision of 0 . 2419 , and F1 score of 0 . 3324 . On the other hand , the worst results were achieved by ResNet101 for such metrics as accuracy ( 0 . 7520 ) and sensitivity ( 0 . 7011 ) . Tables 3 and 4 also show the results for InceptionNetV3 , used in the proposed model . It performed with an AUC of 0 . 7522 , sensitivity of 0 . 7073 , speciï¬city of 0 . 6869 , accuracy of 0 . 6864 , precision of 0 . 2314 , and F1 score of 0 . 3171 . As can be seen , the application of InceptionNetV3 independently has worse results for all metrics than the proposed model . From this fact , it can be concluded that the application of ViT and asymmetric loss function is eï¬€ective for this ï¬eld of research . Considering the above - mentioned results , our model is the most suit - able for the following experiments . 3 . 3 . Experiments with custom dataset This section describes the experiments on our custom dataset con - taining CXR images and clinical data . As mentioned in previous sec - tions , the experimentâ€™s goal is to determine whether treating the patient with CS is recommended . This experiment is divided into two parts . The ï¬rst one is aimed at experimenting only on CXR images . The second part is designed to apply CXR images and clinical data . The pre - trained model from section 3 . 2 is used for both parts . 3 . 3 . 1 . Classiï¬cation of chest X - ray images This part of the experiment is supposed to determine whether the CS treatment is needed , taking into consideration only a CXR image of the patient . The feature extractor is the main part , which is a pre - trained neural network from the previous step ( see subsection 3 . 2 . 1 ) . Instead of adding new layers to a pre - trained network , which would perform the binary classiï¬cation , we applied traditional ML methods to the latent space of the three last layers of the neural network . The combination of NN and traditional ML has been successfully applied in some other works , for example , in [ 54 , 34 , 55 ] . This method was selected because ï¬ne - tuning pre - trained NN and adding several new layers to perform the classiï¬cation can be ineï¬€ective since the dataset is relatively small . The traditional ML algorithms in our experiment were independently applied to the last three layers . Consequently , three diï¬€erent results were achieved . The scheme of the experiment is depicted in Fig . 7 . For the experiment , the following traditional ML algorithms [ 56 ] were evaluated : Random Forest ( RF ) , Multilayer Perceptron ( MLP ) , Lo - gistic Regression ( LR ) , Decision Tree ( DT ) , ğ‘˜ - Nearest Neighbors ( kNN ) , Support Vector Machine ( SVM ) , and AdaBoost . An optimization technique , random search with cross - validation with ï¬ve folds , is used to ï¬nd the best hyper - parameter combination . The found optimal hyper - parameters for diï¬€erent ML methods and dif - ferent outputs from the last layers are shown in Table 5 . 3 . 3 . 2 . Classiï¬cation with mixed data The second part of the experiment aims to determine the necessity of CS , considering the combination of CXR images and clinical data . The experiment scheme is depicted in Fig . 8 . As can be seen , the CXR image is fed into our neural network , which is pre - trained on general pulmonary diseases , where the features are extracted . The outputs from the last layers are concatenated with the preselected clinical features ( see section 3 . 1 . 2 ) . Here , it is considered that additional information can improve the prediction accuracy of the necessity of CS treatment . And , as was described in the previous part , the traditional ML methods are applied independently to each pair layer output + clinical data . There were three experiments because the three last layers were used for the experiment . As was presented in the previous part , the set of ML methods is used the same . Here also the optimization technique , such as random search with cross - validation ( ğ‘› = 5 ) . The optimal hyper - parameters are found and introduced in Table 6 . 4 . Results and discussion This section represents the metrics used for comparing trained mod - els , discusses the achieved results , and the future directions for further research . Computational and Structural Biotechnology Journal 24 ( 2024 ) 53 â€“ 65 61 A . Mezina , S . Genzor , R . Burget et al . Fig . 7 . Overview of the experiment with ï¬ne - tuning and application of ML methods . Table 5 Detected hyper - parameters of machine learning methods for experiments with only CXR . Last layer ( - 1 ) Last layer ( - 2 ) Last layer ( - 3 ) Random Forest number of estimators : 1 , max features : 12 , max depth : 18 , criterion : gini number of estimators : 13 , max features : 17 , max depth : 7 , criterion : gini number of estimators : 3 , max features : 7 , max depth : 18 , criterion : gini MLP solver : lbfgs , max iterations : 140 , hidden layer size : 186 solver : sgd , max iterations : 38 , hidden layer sizes : 172 solver : lbfgs , max iterations : 18 , hidden layer sizes : 112 Logistic Regression solver : saga , max iterations : 4 , C : 3 . 5354 solver : lbfgs , max iterations : 16 , C : 4 . 9495 solver : newton - cg , max iterations : 2 , C : 9 . 7979 Decision Tree max features : log2 , max depth : 7 , criterion : gini max features : auto , max depth : 5 , criterion : gini max features : auto , max depth : 3 , criterion : entropy ğ‘˜ - Nearest Neighbors weights : uniform , number of neighbors : 14 , algorithm : ball tree weights : uniform , number of neighbors : 5 , algorithm : auto weights : uniform , number of neighbors : 5 , algorithm : auto SVM kernel : poly , C : 0 . 5051 kernel : rbf , C : 2 . 0203 kernel : rbf , C : 1 . 8183 AdaBoost number of estimators : 5 , learning rate : 0 . 778 number of estimators : 24 , learning rate : 0 . 445 number of estimators : 21 , learning rate : 0 . 556 Fig . 8 . Overview of the experiment with a combination of CXR and clinical data . Computational and Structural Biotechnology Journal 24 ( 2024 ) 53 â€“ 65 62 A . Mezina , S . Genzor , R . Burget et al . Table 6 Detected hyper - parameters of machine learning methods for experiments with CXR images and clinical data . Last layer ( - 1 ) Last layer ( - 2 ) Last layer ( - 3 ) Random Forest number of estimators : 11 , max features : 17 , max depth : 14 , criterion : entropy number of estimators : 14 , max features : 29 , max depth : 14 , criterion : gini number of estimators : 5 , max features : 21 , max depth : 6 , criterion : gini MLP solver : lbfgs , max iterations : 31 , hidden layer size : 170 solver : adam , max iterations : 99 , hidden layer sizes : 35 solver : adam , max iterations : 130 , hidden layer sizes : 123 Logistic Regression solver : lbfgs , max iterations : 3 , C : 1 . 9599 solver : lbfgs , max iterations : 58 , C : 9 . 7487 solver : lbfgs , max iterations : 54 , C : 1 . 0051 Decision Tree max features : auto , max depth : 4 , criterion : entropy max features : auto , max depth : 12 , criterion : entropy max features : log2 , max depth : 13 , criterion : entropy ğ‘˜ - Nearest Neighbors weights : distance , number of neighbors : 14 , algorithm : ball tree weights : distance , number of neighbors : 14 , algorithm : auto weights : distance , number of neighbors : 14 , algorithm : ball tree SVM kernel : rbf , C : 6 . 3819 kernel : rbf , C : 6 . 3819 kernel : rbf , C : 6 . 3819 AdaBoost number of estimators : 21 , learning rate : 0 . 5793 number of estimators : 23 , learning rate : 0 . 3165 number of estimators : 15 , learning rate : 0 . 8948 4 . 1 . Metrics The metrics used are accuracy , precision , recall , balanced accuracy , and F1 - score , which are usually used in evaluating classiï¬cation tasks . The deï¬nitions of the mentioned metrics are shown below [ 35 ] : ğ´ğ‘ğ‘ğ‘¢ğ‘Ÿğ‘ğ‘ğ‘¦ = ğ‘‡ğ‘ + ğ‘‡ğ‘ƒ ğ‘‡ğ‘ƒ + ğ‘‡ğ‘ + ğ¹ğ‘ƒ + ğ¹ğ‘ , ( 3 ) ğ‘ƒğ‘Ÿğ‘’ğ‘ğ‘–ğ‘ ğ‘–ğ‘œğ‘› = ğ‘‡ğ‘ƒ ğ‘‡ğ‘ƒ + ğ¹ğ‘ƒ , ( 4 ) ğ‘…ğ‘’ğ‘ğ‘ğ‘™ğ‘™ = ğ‘†ğ‘’ğ‘›ğ‘ ğ‘–ğ‘¡ğ‘–ğ‘£ğ‘–ğ‘¡ğ‘¦ = ğ‘‡ğ‘ƒ ğ‘‡ğ‘ƒ + ğ¹ğ‘ , ( 5 ) ğ‘†ğ‘ğ‘’ğ‘ğ‘–ğ‘“ğ‘–ğ‘ğ‘–ğ‘¡ğ‘¦ = ğ‘‡ğ‘ ğ‘‡ğ‘ + ğ¹ğ‘ƒ , ( 6 ) ğ¹ 1 = 2 â‹… ğ‘ƒğ‘Ÿğ‘’ğ‘ğ‘–ğ‘ ğ‘–ğ‘œğ‘› â‹… ğ‘…ğ‘’ğ‘ğ‘ğ‘™ğ‘™ ğ‘ƒğ‘Ÿğ‘’ğ‘ğ‘–ğ‘ ğ‘–ğ‘œğ‘› + ğ‘…ğ‘’ğ‘ğ‘ğ‘™ğ‘™ , ( 7 ) ğ´ğ‘ğ‘ BAL = ğ‘†ğ‘ğ‘’ğ‘ğ‘–ğ‘“ğ‘–ğ‘ğ‘–ğ‘¡ğ‘¦ + ğ‘†ğ‘’ğ‘›ğ‘ ğ‘–ğ‘¡ğ‘–ğ‘£ğ‘–ğ‘¡ğ‘¦ 2 , ( 8 ) where ğ‘‡ğ‘ â€“ number of True Negative cases , ğ‘‡ğ‘ƒ â€“ True Positives , ğ¹ğ‘ƒ â€“ False Positives , ğ¹ğ‘ â€“ False Negatives . 4 . 2 . Classiï¬cation of chest X - ray data This section introduces the results for predicting CS treatment ne - cessity based on CXR images . Table 7 shows the results for diï¬€erent last layers output processed with some traditional ML methods . The best po - tential result for all metrics is 1 , and the worst is 0 . As can be seen , the most successful method is the RF , which was applied for the last layer ( - 3 ) . The results are : accuracy is 0 . 7273 , F1 is 0 . 7059 , balanced accu - racy is 0 . 7267 , and ROC - AUC is 0 . 7247 . However , MLP has the best result for recall 0 . 76 . The kNN method from the last layer ( - 1 ) has the best precision result 0 . 73 . For the other layers , the results are close to the ones mentioned above . For the last layer ( - 1 ) , RF has the best results for accu - racy ( 0 . 7091 ) , F1 ( 0 . 6923 ) , recall ( 0 . 72 ) , balanced accuracy ( 0 . 71 ) , and ROC - AUC ( 0 . 71 ) . The RF performs better than other methods for the last layer ( - 2 ) . It succeeded with an accuracy of 0 . 7091 , F1 of 0 . 6522 , pre - cision of 0 . 7143 , balanced accuracy of 0 . 70 , and a ROC - AUC of 0 . 6933 . DT method is the best for recall ( 0 . 64 ) . Another interesting direction for investigation is the identiï¬cation of the disease that has the most signiï¬cant impact on the decision for CS treatment . As mentioned above , for this experiment , the used neural network was pre - trained on the large dataset ChestX - ray14 , which is la - beled for 14 diï¬€erent pulmonary diseases . The last layer output of this Fig . 9 . SHAP evaluation for the outputs of last layer ( - 1 ) of NN in experiments with only CXR . model is a vector of probabilities of various illnesses . This output is fed into selected traditional ML algorithms , and the decision on CS treat - ment is performed . To investigate , which values of NN output are the most signiï¬cant for decision - making , the SHAP analysis was applied to explain the model . Fig . 9 shows the feature importance for the selected algorithm , in this case , for RF ( accuracy is 0 . 7091 ) . As can be seen , the highest values have the following diseases : Eï¬€usion , Fibrosis , and Edema . The other ones have less impact on output , but it is still high . 4 . 3 . Classiï¬cation of mixed data Another conducted experiment has not only CXR image data but also additional clinical information about every patient ( blood test , spirom - etry , and anamnesis ) . The results are shown in Table 8 . Here , it is more diï¬ƒcult to determine the absolutely successful combination of one of the last layers and the ML method . However , the MLP for the last layer ( - 2 ) has the best results for accuracy ( 0 . 80 ) , balanced accuracy ( 0 . 7867 ) and ROC - AUC ( 0 . 8933 ) . On the other hand , DT for the last layer ( - 1 ) has achieved the best value Computational and Structural Biotechnology Journal 24 ( 2024 ) 53 â€“ 65 63 A . Mezina , S . Genzor , R . Burget et al . Table 7 Results for CS prediction using diï¬€erent last layers of NN for only CXR . Accuracy F1 Precision Recall Balanced Acc ROC - AUC Last layer ( - 1 ) â€“ Result 1 Random Forest 0 . 7091 0 . 6923 0 . 6667 0 . 7200 0 . 7100 0 . 7100 MLP 0 . 6909 0 . 6531 0 . 6667 0 . 6400 0 . 6867 0 . 6760 Logistic Regression 0 . 5818 0 . 2581 0 . 6667 0 . 1600 0 . 5467 0 . 5627 Decision Tree 0 . 6364 0 . 6429 0 . 5806 0 . 7200 0 . 6433 0 . 6007 ğ‘˜ - Nearest Neighbors 0 . 6727 0 . 5500 0 . 7333 0 . 4400 0 . 6533 0 . 6700 SVM 0 . 6000 0 . 5600 0 . 5600 0 . 5600 0 . 5967 0 . 5800 AdaBoost 0 . 5636 0 . 5000 0 . 5217 0 . 4800 0 . 5567 0 . 5547 Last layer ( - 2 ) â€“ Result 2 Random Forest 0 . 7091 0 . 6522 0 . 7143 0 . 6000 0 . 7000 0 . 6933 MLP 0 . 6364 0 . 6364 0 . 6364 0 . 6364 0 . 6364 0 . 6364 Logistic Regression 0 . 6727 0 . 6250 0 . 6522 0 . 6000 0 . 6667 0 . 6000 Decision Tree 0 . 5818 0 . 5818 0 . 5333 0 . 6400 0 . 5867 0 . 5647 ğ‘˜ - Nearest Neighbors 0 . 6182 0 . 5882 0 . 5769 0 . 6000 0 . 6167 0 . 5907 SVM 0 . 6000 0 . 5217 0 . 5714 0 . 4800 0 . 5900 0 . 4380 AdaBoost 0 . 6545 0 . 5957 0 . 6364 0 . 5600 0 . 6467 0 . 6367 Last layer ( - 3 ) â€“ Result 3 Random Forest 0 . 7273 0 . 7059 0 . 6923 0 . 7200 0 . 7267 0 . 7247 MLP 0 . 6909 0 . 6909 0 . 6333 0 . 7600 0 . 6967 0 . 6693 Logistic Regression 0 . 6909 0 . 6383 0 . 6818 0 . 6000 0 . 6833 0 . 6533 Decision Tree 0 . 6000 0 . 6071 0 . 5484 0 . 6800 0 . 6067 0 . 6213 ğ‘˜ - Nearest Neighbors 0 . 6545 0 . 6545 0 . 6000 0 . 7200 0 . 6600 0 . 6653 SVM 0 . 5818 0 . 4889 0 . 5500 0 . 4400 0 . 5700 0 . 4213 AdaBoost 0 . 5818 0 . 5490 0 . 5385 0 . 5600 0 . 5800 0 . 5633 Table 8 Results for CS prediction using clinical data and diï¬€erent last layers of NN for CXR . Accuracy F1 Precision Recall Balanced Acc ROC - AUC Last layer ( - 1 ) â€“ Result 4 Random Forest 0 . 7273 0 . 7059 0 . 6923 0 . 7200 0 . 7267 0 . 6840 Logistic Regression 0 . 6182 0 . 5714 0 . 5833 0 . 5600 0 . 6133 0 . 6547 Decision Tree 0 . 7636 0 . 7869 0 . 6667 0 . 9600 0 . 7800 0 . 7033 MLP 0 . 7455 0 . 7407 0 . 6897 0 . 8000 0 . 7500 0 . 7667 ğ‘˜ - Nearest Neighbors 0 . 6727 0 . 6250 0 . 6522 0 . 6000 0 . 6667 0 . 6973 SVM 0 . 5818 0 . 4889 0 . 5500 0 . 4400 0 . 5700 0 . 7053 AdaBoost 0 . 6364 0 . 6296 0 . 5862 0 . 6800 0 . 6400 0 . 5967 Last layer ( - 2 ) â€“ Result 5 Random Forest 0 . 7455 0 . 7308 0 . 7037 0 . 7600 0 . 7467 0 . 7827 Logistic Regression 0 . 6182 0 . 5882 0 . 5769 0 . 6000 0 . 6167 0 . 6507 Decision Tree 0 . 6545 0 . 5957 0 . 6364 0 . 5600 0 . 6467 0 . 6467 MLP 0 . 8000 0 . 7442 0 . 8889 0 . 6400 0 . 7867 0 . 8933 ğ‘˜ - Nearest Neighbors 0 . 6909 0 . 6383 0 . 6818 0 . 6000 0 . 6833 0 . 7093 SVM 0 . 5818 0 . 4889 0 . 5500 0 . 4400 0 . 5700 0 . 7053 AdaBoost 0 . 6364 0 . 5652 0 . 6190 0 . 5200 0 . 6267 0 . 5540 Last layer ( - 3 ) â€“ Result 6 Random Forest 0 . 7455 0 . 7308 0 . 7037 0 . 7600 0 . 7467 0 . 7727 Logistic Regression 0 . 6182 0 . 5882 0 . 5769 0 . 6000 0 . 6167 0 . 6413 Decision Tree 0 . 6727 0 . 6250 0 . 6522 0 . 6000 0 . 6667 0 . 6973 MLP 0 . 7636 0 . 6486 1 . 0000 0 . 4800 0 . 7400 0 . 8467 ğ‘˜ - Nearest Neighbors 0 . 6909 0 . 6383 0 . 6818 0 . 6000 0 . 6833 0 . 7053 SVM 0 . 5818 0 . 4889 0 . 5500 0 . 4400 0 . 5700 0 . 7053 AdaBoost 0 . 6545 0 . 6122 0 . 6250 0 . 6000 0 . 6500 0 . 6047 of F1 ( 0 . 7869 ) and recall ( 0 . 96 ) . Finally , MLP for the last layer ( - 3 ) has the absolute result for precision ( 1 . 0 ) . Despite such diï¬€erent results , comparing Tables 7 and 8 , it can be concluded that the combination of CXR and clinical data gives more accurate results than those performed only for CXR images . Here , it can also be noticed that using outputs from the last layer can beneï¬t the practical side . As less abstraction is used for decisions , it is easier to interpret the results . As mentioned in the previous section , the last layer of NN indicates the probability of a pulmonary disease . Another point that would be considered is the importance of met - rics . In some cases , paying attention to the rate of false negatives would be more essential since the missed therapy can be crucial for a patient . On the other side , considering several metrics can be more informative since they can give complete information regarding tested methods . Consequently , some weak sides can be identiï¬ed . However , all these points should be consulted with experts ( doctors ) who will use the methodology . Compared to our previous work [ 35 ] , this approach has improved the capability of CS treatment prediction for more than 6 % accuracy . Here , it can be concluded that additional information , such as CXR is useful in CS treatment prediction . Notably , the proposed methodology is more complex than the previous one , which indicates that this research ï¬eld requires advanced processing methods . On the other hand , the problem of interpretation is arising . In previous work , the decision tree can be quickly drawn and the doctors can evaluate the correctness of the algorithm . However , in case of neural networks , it is getting more complicated , and several additional techniques are required to reveal the reasons for algorithm decisions . 4 . 4 . Summary and future work According to relatively good results , it can be concluded that the ap - plication of AI for preventive CS treatment can accurately recommend CS treatment to patients who can potentially beneï¬t from the treat - Computational and Structural Biotechnology Journal 24 ( 2024 ) 53 â€“ 65 64 A . Mezina , S . Genzor , R . Burget et al . ment and not recommend it to patients who , with a high probability , will not beneï¬t from it and in this way , overtreatment will be avoided . We also conclude that combining the raw CXR image data with clinical data is signiï¬cantly more accurate than just CXR images . Despite the application of relatively computation - demanding architectures , such as InceptionNet and Vision Transformer , the proposed architecture can be applied to real - world environments . This is proved by deploying the methodology into the internal hospital system . This work attempted to use the optimal input image size so that the details would be preserved , and it is not computationally demanding . On the other hand , if this methodology is applied in another hospital environment , it is necessary to consider the allowed latency , processing time , and frequency of us - age . Depending on these points , the hardware should be chosen wisely . However , this work has some issues and requires some improvements . Firstly , the relatively small custom dataset is used , which is why the overï¬tting problem can appear . As future work , this dataset is sup - posed to be extended , especially with the appearance of new mutations . Here it is also worth mentioning , that some patients were diagnosed with other methods , than anti - SARS - CoV - 2 IgG testing , but with clini - cal symptoms , radiology image , and presence of anti - SARS - CoV - 2 IgM antibodies . It indicates , that other clinical information should also be considered during patient examination and treatment prescription . Secondly , in this work , the model was pre - trained on general pul - monary diseases . However , in future work , the model should be pre - trained also on COVID - 19 datasets . It would make the NN more adapted to the problems related to COVID - 19 . Thirdly , this paper utilizes the two methods of feature selection . However , the following work can extend this part too : more detailed analysis of clinical data using statistical methods and diï¬€erent param - eter selection techniques is required . One of the possible directions is to use feature selection based on genetic algorithms as was proposed in [ 57 ] . Another raised problem is the interpretation of algorithm decision - making . Since the neural network is a kind of â€œblack - boxâ€ it is necessary to apply the advanced interpretation techniques of such methods . This point will be addressed in future work . Considering the complexity of ML / DL methods , it is reasonable to experiment with other techniques , for example , fuzzy similarities [ 58 , 59 ] . Lastly , based on the received information on the patient and his treatment , the work can be extended by evaluating the severity and duration of the post - acute phase . 5 . Conclusion Prevention , diagnostics , and treatment of COVID - 19 have improved signiï¬cantly in recent years . However , severe cases may lead to long - term complications that may increase worldwide morbidity . One of the most severe complications is PF , which can be preventively treated us - ing CS . Unfortunately , CS treatment has severe side eï¬€ects , and the non - selected application of CS is considered harmful . Currently , no methodology can identify people who will beneï¬t from the treatment and who will not . This work introduced a novel , personalized AI - based methodology for CS treatment prescription during the post - acute phase of COVID - 19 . For the design of the methodology , we collected data from a total of 273 patients , which consist of more than 100 diï¬€erent parameters for each person . It includes data that were collected at the ï¬rst examination of post - COVID treatment ( blood tests , spirometry test , anamnesis , and CXR images ) , which is , regarding its detail , the largest reported dataset . The proposed methodology is based on a neural network architec - ture pre - trained on a large dataset of pulmonary diseases ChestX - ray14 . In this way , the neural network can extract the relevant features from input images . The ï¬rst experiment is based on the processing of a CXR image by NN and the traditional ML algorithm with optimization , which was applied to get the ï¬nal decision on the necessity of CS treatment . The second experiment has the additional part : clinical data concate - nated to the NN output for the ï¬nal decision . Here results from CXR and a combination of CXR with clinical in - formation were evaluated . We demonstrated that combining CXR and clinical information achieves signiï¬cantly better results ( 78 . 7 % ) . The proposed methodology can be used in real - world practice . It can assist physicians in identifying individuals who need CS treatment . For sure , this ï¬eld of research is promising . It can help improve the speed of the patientâ€™s examination , and more people would get personalized medical care and avoid overtreatment of patients who will not beneï¬t from the treatment . The same principle may be applied to other diseases with a risk of PF development ( e . g . , organizing pneumonia , acute respi - ratory distress syndrome , or drug - induced lung involvement ) . This way , the pandemic of COVID - 19 may give us lessons for future applications of AI . Informed consent statement Patient consent was waived because the analysis was conducted on anonymized retrospective medical records . Institutional review board statement The study was conducted in accordance with the Declaration of Helsinki , and approved by the Ethics Committee of University Hospital Olomouc and Faculty of Medicine and Dentistry ( protocol code 228 / 21 , approved 13 . 12 . 2021 ) . CRediT authorship contribution statement Anzhelika Mezina : Conceptualization , Investigation , Methodology , Writing â€“ original draft . Samuel Genzor : Data curation , Formal anal - ysis , Investigation , Writing â€“ review & editing , Funding acquisition . Radim Burget : Funding acquisition , Project administration , Supervi - sion , Writing â€“ review & editing . Vojtech Myska : Data curation , Formal analysis , Writing â€“ review & editing . Jan Mizera : Data curation , Formal analysis , Investigation , Writing â€“ review & editing . Aleksandr Ometov : Project administration , Supervision , Writing â€“ review & editing . Declaration of competing interest The authors declare that they have no known competing ï¬nancial interests or personal relationships that could have appeared to inï¬‚uence the work reported in this paper . Funding This work was supported by the Ministry of the Interior of the Czech Republic ( MVCR ) under the program OPSEC with number VK01010153 . This work was supported by the Ministry of Education Youth and Sports of the Czech Republic under the program â€œEducation at UP 22 + edUPâ€ with number NPO _ UPOL _ MSMT - 16589 / 2022 . References [ 1 ] Ma Q , Liu J , Liu Q , Kang L , Liu R , Jing W , et al . Global percentage of asymptomatic SARS - CoV - 2 infections among the tested population and individuals with conï¬rmed COVID - 19 diagnosis . JAMA Netw Open 2021 ; 4 : e2137257 . [ 2 ] Desai AD , Lavelle M , Boursiquot BC , Wan EY . Long - term complications of COVID - 19 . Am J Physiol , Cell Physiol 2022 ; 322 : C1 â€“ 11 . [ 3 ] Zhang C , Wu Z , Li J - W , Tan K , Yang W , Zhao H , et al . Discharge may not be the end of treatment : pay attention to pulmonary ï¬brosis caused by severe COVID - 19 . J Med Virol 2021 ; 93 : 1378 â€“ 86 . [ 4 ] Myall KJ , Mukherjee B , Castanheira AM , Lam JL , Benedetti G , Mak SM , et al . Persistent post â€“ COVID - 19 interstitial lung disease . An observational study of cor - ticosteroid treatment . Ann Am Thorac Soc 2021 ; 18 : 799 â€“ 806 . Computational and Structural Biotechnology Journal 24 ( 2024 ) 53 â€“ 65 65 A . Mezina , S . Genzor , R . Burget et al . [ 5 ] Bieksiene K , Zaveckiene J , Malakauskas K , Vaguliene N , Zemaitis M , Miliauskas S . Post COVID - 19 organizing pneumonia : the right time to interfere . Medicina 2021 ; 57 : 283 . [ 6 ] Sarfraz A , Sarfraz Z , Razzack AA , Patel G , Sarfraz M . Venous thromboembolism , corticosteroids and COVID - 19 : a systematic review and meta - analysis . Clin Appl Thromb / Hemost 2021 ; 27 : 1076029621993573 . [ 7 ] Volmer T , Eï¬€enberger T , Trautner C , Buhl R . Consequences of long - term oral corti - costeroid therapy and its side - eï¬€ects in severe asthma in adults : a focused review of the impact data in the literature . Eur Respir J 2018 ; 52 . [ 8 ] Mongardon N , Piagnerelli M , Grimaldi D , Perrot B , Lascarrou J - B . Impact of late administration of corticosteroids in COVID - 19 ARDS . Intensive Care Med 2021 ; 47 : 110 â€“ 2 . [ 9 ] Tlayjeh H , Mhish OH , Enani MA , Alruwaili A , Tleyjeh R , Thalib L , et al . Association of corticosteroids use and outcomes in COVID - 19 patients : a systematic review and meta - analysis . J Infect Publ Health 2020 ; 13 : 1652 â€“ 63 . [ 10 ] Nabahati M , Ebrahimpour S , Khaleghnejad Tabari R , Mehraeen R . Post - COVID - 19 pulmonary ï¬brosis and its predictive factors : a prospective study . Egypt J Radiol Nucl Med 2021 ; 52 : 1 â€“ 7 . [ 11 ] dataset CS . https : / / drive . google . com / drive / u / 2 / folders / 1F9cjEcptMpc8nbFuKR _ SQ0O - sY4Op3L4 . [ Accessed 13 January 2023 ] ; 2023 . [ 12 ] Dansana D , Kumar R , Bhattacharjee A , Hemanth DJ , Gupta D , Khanna A , et al . Early diagnosis of COVID - 19 - aï¬€ected patients based on X - ray and computed tomography images using deep learning algorithm . Soft Comput 2020 : 1 â€“ 9 . [ 13 ] Mettler Jr FA , Huda W , Yoshizumi TT , Mahesh M . Eï¬€ective doses in radiology and diagnostic nuclear medicine : a catalog . Radiology 2008 ; 248 : 254 â€“ 63 . [ 14 ] Murphy K , Smits H , Knoops AJ , Korst MB , Samson T , Scholten ET , et al . COVID - 19 on chest radiographs : a multireader evaluation of an artiï¬cial intelligence system . Radiology 2020 ; 296 : E166 â€“ 72 . [ 15 ] He K , Zhang X , Ren S , Sun J . Deep residual learning for image recognition . In : Proceedings of the IEEE conference on computer vision and pattern recognition ; 2016 . p . 770 â€“ 8 . [ 16 ] Huang G , Liu Z , Van Der Maaten L , Weinberger KQ . Densely connected convolu - tional networks . In : Proceedings of the IEEE conference on computer vision and pattern recognition ; 2017 . p . 4700 â€“ 8 . [ 17 ] Szegedy C , Vanhoucke V , Ioï¬€e S , Shlens J , Wojna Z . Rethinking the inception ar - chitecture for computer vision . In : Proceedings of the IEEE conference on computer vision and pattern recognition ; 2016 . p . 2818 â€“ 26 . [ 18 ] Sitaula C , Hossain MB . Attention - based VGG - 16 model for COVID - 19 chest X - ray image classiï¬cation . Appl Intell 2021 ; 51 : 2850 â€“ 63 . [ 19 ] Nishio M , Kobayashi D , Nishioka E , Matsuo H , Urase Y , Onoue K , et al . Deep learning model for the automatic classiï¬cation of COVID - 19 pneumonia , non - COVID - 19 pneumonia , and the healthy : a multi - center retrospective study . Sci Rep 2022 ; 12 : 8214 . [ 20 ] Nishio M , Noguchi S , Matsuo H , Murakami T . Automatic classiï¬cation between COVID - 19 pneumonia , non - COVID - 19 pneumonia , and the healthy on chest X - ray image : combination of data augmentation methods . Sci Rep 2020 ; 10 : 17532 . [ 21 ] Wehbe RM , Sheng J , Dutta S , Chai S , Dravid A , Barutcu S , et al . DeepCOVID - XR : an artiï¬cial intelligence algorithm to detect COVID - 19 on chest radiographs trained and tested on a large U . S . clinical data set . Radiology 2021 ; 299 : E167 . [ 22 ] Zhang R , Tie X , Qi Z , Bevins NB , Zhang C , Griner D , et al . Diagnosis of coronavirus disease 2019 pneumonia by using chest radiography : value of artiï¬cial intelligence . Radiology 2021 ; 298 : E88 â€“ 97 . [ 23 ] Jia G , Lam H - K , Xu Y . Classiï¬cation of COVID - 19 chest X - Ray and CT images using a type of dynamic CNN modiï¬cation method . Comput Biol Med 2021 ; 134 : 104425 . [ 24 ] Khan E , Rehman MZU , Ahmed F , Alfouzan FA , Alzahrani NM , Ahmad J . Chest X - ray classiï¬cation for the detection of COVID - 19 using deep learning techniques . Sensors 2022 ; 22 : 1211 . [ 25 ] Gour M , Jain S . Uncertainty - aware convolutional neural network for COVID - 19 X - ray images classiï¬cation . Comput Biol Med 2022 ; 140 : 105047 . [ 26 ] Sharma A , Singh K , Koundal D . A novel fusion based convolutional neural network approach for classiï¬cation of COVID - 19 from chest X - ray images . Biomed Signal Process Control 2022 ; 77 : 103778 . [ 27 ] Bargshady G , Zhou X , Barua PD , Gururajan R , Li Y , Acharya UR . Application of CycleGAN and transfer learning techniques for automated detection of COVID - 19 using X - ray images . Pattern Recognit Lett 2022 ; 153 : 67 â€“ 74 . [ 28 ] Hussain E , Hasan M , Rahman MA , Lee I , Tamanna T , Parvez MZ . CoroDet : a deep learning based classiï¬cation for COVID - 19 detection using chest X - ray images . Chaos Solitons Fractals 2021 ; 142 : 110495 . [ 29 ] Shamout FE , Shen Y , Wu N , Kaku A , Park J , Makino T , et al . An artiï¬cial intelligence system for predicting the deterioration of COVID - 19 patients in the emergency de - partment . npj Digit Med 2021 ; 4 : 1 â€“ 11 . [ 30 ] Soda P , Dâ€™Amico NC , Tessadori J , Valbusa G , Guarrasi V , Bortolotto C , et al . AIfor - COVID : predicting the clinical outcomes in patients with COVID - 19 applying AI to chest - X - rays . An Italian multicentre study . Med Image Anal 2021 ; 74 : 102216 . [ 31 ] Ahsan MM , Alam TE , Trafalis T , Huebner P . Deep MLP - CNN model using mixed - data to distinguish between COVID - 19 and non - COVID - 19 patients . Symmetry 2020 ; 12 : 1526 . [ 32 ] Khan IU , Aslam N , Anwar T , Alsaif HS , Chrouf SMB , Alzahrani NA , et al . Using a deep learning model to explore the impact of clinical data on COVID - 19 diagnosis using chest X - ray . Sensors 2022 ; 22 : 669 . [ 33 ] Jiao Z , Choi JW , Halsey K , Tran TML , Hsieh B , Wang D , et al . Prognostication of patients with covid - 19 using artiï¬cial intelligence based on chest x - rays and clinical data : a retrospective study . Lancet Digit Health 2021 ; 3 : e286 â€“ 94 . [ 34 ] Chieregato M , Frangiamore F , Morassi M , Baresi C , Nici S , Bassetti C , et al . A hy - brid machine learning / deep learning COVID - 19 severity predictive model from CT images and clinical data . Sci Rep 2022 ; 12 : 1 â€“ 15 . [ 35 ] Myska V , Genzor S , Mezina A , Burget R , Mizera J , Stybnar M , et al . Artiï¬cial - intelligence - driven algorithms for predicting response to corticosteroid treatment in patients with post - acute COVID - 19 . Diagnostics 2023 ; 13 : 1755 . [ 36 ] Jin C , Yu H , Ke J , Ding P , Yi Y , Jiang X , et al . Predicting treatment response from longitudinal images using multi - task deep learning . Nat Commun 2021 ; 12 : 1 â€“ 11 . [ 37 ] Lou B , Doken S , Zhuang T , Wingerter D , Gidwani M , Mistry N , et al . An image - based deep learning framework for individualising radiotherapy dose : a retrospective anal - ysis of outcome prediction . Lancet Digit Health 2019 ; 1 : e136 â€“ 47 . [ 38 ] Gosselt HR , Verhoeven MM , BulatoviÂ´c - Â´Calasan M , Welsing PM , de Rotte MC , Hazes JM , et al . Complex machine - learning algorithms and multivariable logistic regression on par in the prediction of insuï¬ƒcient clinical response to methotrexate in rheumatoid arthritis . J Personalized Med 2021 ; 11 : 44 . [ 39 ] Mottaqi MS , Mohammadipanah F , Sajedi H . Contribution of machine learn - ing approaches in response to SARS - CoV - 2 infection . Inform Med Unlocked 2021 ; 23 : 100526 . [ 40 ] Elghamrawy S , Hassanien AE . Diagnosis and prediction model for COVID - 19 pa - tientâ€™s response to treatment based on convolutional neural networks and whale optimization algorithm using CT images . medRxiv . https : / / doi . org / 10 . 1101 / 2020 . 04 . 16 . 20063990 , 2020 . [ 41 ] Wang X , Peng Y , Lu L , Lu Z , Bagheri M , Summers RM . ChestX - ray8 : hospital - scale chest X - ray database and benchmarks on weakly - supervised classiï¬cation and lo - calization of common thorax diseases . In : Proceedings of the IEEE conference on computer vision and pattern recognition ; 2017 . p . 2097 â€“ 106 . [ 42 ] Source code . https : / / github . com / aimezina / cs _ treatment _ ai _ prediction . [ Accessed13 January 2023 ] ; 2023 . [ 43 ] Lundberg SM , Erion G , Chen H , DeGrave A , Prutkin JM , Nair B , et al . From local explanations to global understanding with explainable AI for trees . Nat Mach Intell 2020 ; 2 : 2522 â€“ 5839 . [ 44 ] Verploegh IS , Lazar NA , Bartels RH , Volovici V . Evaluation of the use of P values in neurosurgical literature : from statistical signiï¬cance to clinical irrelevance . World Neurosurg 2022 ; 161 : 280 â€“ 3 . [ 45 ] Ronneberger O , Fischer P , Brox T . U - Net : convolutional networks for biomedical image segmentation . In : International conference on medical image computing and computer - assisted intervention . Springer ; 2015 . p . 234 â€“ 41 . [ 46 ] Mezina A , Burget R . Detection of post - COVID - 19 - related pulmonary diseases in X - ray images using Vision Transformer - based neural network . Biomed Signal Process Control 2024 ; 87 : 105380 . [ 47 ] LuB , LuktarhanN , DingC , ZhangW . ICLSTM : encrypted traï¬ƒc service identiï¬cation based on inception - LSTM neural network . Symmetry 2021 ; 13 : 1080 . [ 48 ] Dong Y , Liu Q , Du B , Zhang L . Weighted feature fusion of convolutional neural network and graph attention network for hyperspectral image classiï¬cation . IEEE Trans Image Process 2022 ; 31 : 1559 â€“ 72 . [ 49 ] Dosovitskiy A , Beyer L , Kolesnikov A , Weissenborn D , Zhai X , Unterthiner T , et al . An image is worth 16x16 words : transformers for image recognition at scale . arXiv preprint arXiv : 2010 . 11929 , 2020 . [ 50 ] Ben - Baruch E , Ridnik T , Zamir N , Noy A , Friedman I , Protter M , et al . Asymmetric loss for multi - label classiï¬cation . arXiv preprint arXiv : 2009 . 14119 , 2020 . [ 51 ] Lin T - Y , Goyal P , Girshick R , He K , DollÃ¡r P . Focal loss for dense object detec - tion . In : Proceedings of the IEEE international conference on computer vision ; 2017 . p . 2980 â€“ 8 . [ 52 ] Tan M , Le Q . Eï¬ƒcientNet : rethinking model scaling for convolutional neural net - works . In : International conference on machine learning . PMLR ; 2019 . p . 6105 â€“ 14 . [ 53 ] Simonyan K , Zisserman A . Very deep convolutional networks for large - scale image recognition . arXiv preprint arXiv : 1409 . 1556 , 2014 . [ 54 ] Zhou C , Song J , Zhou S , Zhang Z , Xing J . COVID - 19 detection based on image re - grouping and resnet - SVM using chest X - ray images . IEEE Access 2021 ; 9 : 81902 â€“ 12 . [ 55 ] Yu Z , Li X , Sun H , Wang J , Zhao T , Chen H , et al . Rapid identiï¬cation of COVID - 19 severity in CT scans through classiï¬cation of deep features . Biomed Eng Online 2020 ; 19 : 1 â€“ 13 . [ 56 ] Rhys H . Machine learning with R , the tidyverse , and mlr . Simon and Schuster ; 2020 . [ 57 ] Bhuvaneswari G , Manikandan G . A novel machine learning framework for diagnos - ing the type 2 diabetics using temporal fuzzy ant miner decision tree classiï¬er with temporal weighted genetic algorithm . Computing 2018 ; 100 : 759 â€“ 72 . [ 58 ] Versaci M , Angiulli G , La Foresta F , Crucitti P , LaganÃ¡ F , PellicanÃ³ D , et al . Inno - vative soft computing techniques for the evaluation of the mechanical stress state of steel plates . In : International conference on applied intelligence and informatics . Springer ; 2022 . p . 14 â€“ 28 . [ 59 ] Donyatalab Y , GÃ¼ndoË˜gdu FK , Farid F , Seyï¬ - Shishavan SA , Farrokhizadeh E , Kahra - manC . Novel spherical fuzzy distance and similarity measures and their applications to medical diagnosis . Expert Syst Appl 2022 ; 191 : 116330 .